Operation of a facility testing malaria vaccines in adult human subjects

Ended Awarded Last action

Contract number
HHSN27200001
Awardee
Awarding agency
Obligated
$19,338

Award facts

Opportunity
  • NIHAO2015023 Solicitation number
Contract value 100% obligated
$19,338.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Sanaria pfspz challenge with pyrimethamine chemoprophylxis (pfspz-cvac approach): phase 1 trial $0
Original award $19,338

Quick answers

Who was awarded contract HHSN27200001?

HHSN27200001 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2016.

How much is contract HHSN27200001 worth?

The government has obligated $19,338 on HHSN27200001.

Is contract HHSN27200001 an order under another contract?

Yes. HHSN27200001 is a delivery order under HHSN272201600003I, an indefinite delivery contract, on Facility Management for Malaria Vaccine Testing.

Was contract HHSN27200001 competed?

The extent of competition for HHSN27200001 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award